Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Fourmy

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 8, 2009
Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramicsHélène Autefage, Fabienne Briand-Mésange, Sophie Cazalbou, et al.
Scientific Reports|October 6, 2022
Reduction of stress responses in honey bees by synthetic ligands targeting an allatostatin receptorAdrià Sánchez-Morales, Véronique Gigoux, Minos-Timotheos Matsoukas, et al.
Plos One|January 8, 2016
Honey Bee Allatostatins Target Galanin/Somatostatin-Like Receptors and Modulate Learning: A Conserved Function?Elodie Urlacher, Laurent Soustelle, Marie-Laure Parmentier, et al.
The Journal of Biological Chemistry|November 29, 2001
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation processChantal Escrieut, Véronique Gigoux, Elodie Archer, et al.
Biochemical Pharmacology|September 20, 2016
Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomesSadek Ismail, Marie-Julie Gherardi, Alexander Froese, et al.
Nanoscale Advances|September 22, 2022
Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fieldsSara Lopez, Nicolas Hallali, Yoann Lalatonne, et al.
Pharmacology & Toxicology|April 12, 2003
Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonistsDaniel Fourmy, Chantal Escrieut, Elodie Archer, et al.
Journal of Medicinal Chemistry|July 22, 2005
Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptorMercedes Martín-Martínez, Anne Marty, Maud Jourdan, et al.
Molecular and Cellular Biology|December 29, 2011
A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathwaySouad Najib, Nathalie Saint-Laurent, Jean-Pierre Estève, et al.
The Journal of Biological Chemistry|January 6, 2005
Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptorElodie Archer-Lahlou, Chantal Escrieut, Pascal Clerc, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 8, 2009
Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramicsHélène Autefage, Fabienne Briand-Mésange, Sophie Cazalbou, et al.
Scientific Reports|October 6, 2022
Reduction of stress responses in honey bees by synthetic ligands targeting an allatostatin receptorAdrià Sánchez-Morales, Véronique Gigoux, Minos-Timotheos Matsoukas, et al.
Plos One|January 8, 2016
Honey Bee Allatostatins Target Galanin/Somatostatin-Like Receptors and Modulate Learning: A Conserved Function?Elodie Urlacher, Laurent Soustelle, Marie-Laure Parmentier, et al.
The Journal of Biological Chemistry|November 29, 2001
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation processChantal Escrieut, Véronique Gigoux, Elodie Archer, et al.
Biochemical Pharmacology|September 20, 2016
Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomesSadek Ismail, Marie-Julie Gherardi, Alexander Froese, et al.
Nanoscale Advances|September 22, 2022
Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fieldsSara Lopez, Nicolas Hallali, Yoann Lalatonne, et al.
Pharmacology & Toxicology|April 12, 2003
Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonistsDaniel Fourmy, Chantal Escrieut, Elodie Archer, et al.
Journal of Medicinal Chemistry|July 22, 2005
Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptorMercedes Martín-Martínez, Anne Marty, Maud Jourdan, et al.
Molecular and Cellular Biology|December 29, 2011
A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathwaySouad Najib, Nathalie Saint-Laurent, Jean-Pierre Estève, et al.
The Journal of Biological Chemistry|January 6, 2005
Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptorElodie Archer-Lahlou, Chantal Escrieut, Pascal Clerc, et al.
Pageof 8